Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Padoan

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Clinical Reviews in Allergy & Immunology|March 23, 2026
Evolving Therapeutic Strategies in ANCA-Associated Vasculitis: Current Standards and Emerging Targets for GPA and MPARoberto Dal Pozzolo, Luca Iorio, Federica Davanzo, et al.
Seminars in Arthritis and Rheumatism|March 17, 2020
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitisAlvise Berti, Mara Felicetti, Sara Monti, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 12, 2019
Fully integrated [18F]FDG PET/MR in large vessel vasculitisRoberto Padoan, Filippo Crimì, Mara Felicetti, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2020
Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitisRoberto Padoan, Fulvia Chieco Bianchi, Maria Rita Marchi, et al.
Clinical and Experimental Medicine|June 22, 2026
Inflammatory blood count ratios discriminate disease activity and remain persistently elevated during glucocorticoid-free remission in ANCA-associated vasculitisFederica Davanzo, Luca Iorio, Michela Pelloso, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 2, 2020
Health-Related Quality of Life in Patients With ANCA-Associated Vasculitis and Sinonasal Involvement: A Single-Center Cross-Sectional StudyDiego Cazzador, Roberto Padoan, Roberta Colangeli, et al.
Annals of Medicine|November 3, 2025
Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experienceFederica Davanzo, Luca Iorio, Marta Codirenzi, et al.
Diagnostics (Basel, Switzerland)|October 14, 2023
Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory MyopathiesAnna Ghirardello, Mariele Gatto, Chiara Franco, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 1, 2026
Immature leukocyte and plasma-induced cell death reveal subclinical immune activation in EGPA patients in remissionChiara Baggio, Luca Iorio, Carlotta Boscaro, et al.
Frontiers in Immunology|June 30, 2026
Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort studyMarta Codirenzi, Federica Davanzo, Luca Iorio, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Clinical Reviews in Allergy & Immunology|March 23, 2026
Evolving Therapeutic Strategies in ANCA-Associated Vasculitis: Current Standards and Emerging Targets for GPA and MPARoberto Dal Pozzolo, Luca Iorio, Federica Davanzo, et al.
Seminars in Arthritis and Rheumatism|March 17, 2020
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitisAlvise Berti, Mara Felicetti, Sara Monti, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 12, 2019
Fully integrated [18F]FDG PET/MR in large vessel vasculitisRoberto Padoan, Filippo Crimì, Mara Felicetti, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2020
Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitisRoberto Padoan, Fulvia Chieco Bianchi, Maria Rita Marchi, et al.
Clinical and Experimental Medicine|June 22, 2026
Inflammatory blood count ratios discriminate disease activity and remain persistently elevated during glucocorticoid-free remission in ANCA-associated vasculitisFederica Davanzo, Luca Iorio, Michela Pelloso, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 2, 2020
Health-Related Quality of Life in Patients With ANCA-Associated Vasculitis and Sinonasal Involvement: A Single-Center Cross-Sectional StudyDiego Cazzador, Roberto Padoan, Roberta Colangeli, et al.
Annals of Medicine|November 3, 2025
Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experienceFederica Davanzo, Luca Iorio, Marta Codirenzi, et al.
Diagnostics (Basel, Switzerland)|October 14, 2023
Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory MyopathiesAnna Ghirardello, Mariele Gatto, Chiara Franco, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 1, 2026
Immature leukocyte and plasma-induced cell death reveal subclinical immune activation in EGPA patients in remissionChiara Baggio, Luca Iorio, Carlotta Boscaro, et al.
Frontiers in Immunology|June 30, 2026
Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort studyMarta Codirenzi, Federica Davanzo, Luca Iorio, et al.
Pageof 8